Would you consider adding IO therapy to 1st-line platinum/etoposide in a patient with metastatic extrapulmonary small cell carcinoma?

Topics: Genitourinary Cancers • Bladder Cancer • Medical Oncology

Patient has small cell carcinoma of the bladder with extensive hepatic metastases. Would you extrapolate the approach from IMpower133?

Answer from: Medical Oncologist at Academic Institution

The use of platinum based chemotherapy for extra pulmonary small cell is a tradition that has some data to support its use, but the majority of enthusiasm stems from its efficacy in pulmonary small cell. The use of IOs in small cell is now reshaping the field and thus brings this type of quest...

Comments

Medical Oncologist at East Carolina University
Yes, patient is platinum-eligible, therefore recei...

Medical Oncologist at University of Alabama School of Medicine
Since most of the regimens in this space extrapola...

Related Questions